Search for: "AstraZeneca Inc."
Results 321 - 340
of 340
Sort by Relevance
|
Sort by Date
9 Aug 2007, 9:31 am
AstraZeneca Study Information Provided To Regulatory Agencies In May 2007 Currently The Subject of Their Ongoing Safety Reviews (Posted by Tom Lamb at DrugInjuryWatch.com) On August 9, 2007 the FDA and Health Canada issued email alerts about possible serious cardiac events in patients using the prescription heartburn drugs Nexium (esomeprazole) and Prilosec (omeprazole), made by AstraZeneca (AZN). [read post]
25 Jul 2007, 3:15 pm
Astra offers no convincing reason why Emert does not apply.2 See also Geneva Pharms., Inc. v. [read post]
17 Jul 2007, 2:01 pm
Also, the media giant's board should dispose of publishing unit Time Inc., says Pali analyst Richard Greenfield. [read post]
3 Jul 2007, 6:22 am
Pfizer, Inc., ___ F. [read post]
1 Jul 2007, 9:07 pm
Astrazeneca Pharmaceuticals LP et. al. v. [read post]
26 Jun 2007, 7:00 am
Mentor H/S, Inc., 426 F. [read post]
25 Jun 2007, 2:04 am
Supreme Court on Monday [June 25, 2007] turned away a challenge to a "reverse payments" deal between an AstraZeneca PLC unit and a Barr Pharmaceuticals Inc. unit to delay marketing of a generic breast-cancer drug.The rejection came after the U.S. [read post]
9 May 2007, 1:28 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
3 May 2007, 5:45 am
"New DealsThursday, May 3, 2007By Janine Friend"London-based AstraZeneca plc has agreed to buy MedImmune for a total of $15.2 billion. [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
26 Apr 2007, 2:32 am
BusinessWeek notes another Congressional hearing on patent reform will occur on April 26, with testimony from Kevin Sharer, chief executive of biotech company Amgen Inc.; Anthony Peterman, patent counsel for computer manufacturer Dell Inc.; and Gary Griswold, president and chief counsel of intellectual property at 3M Co.Dell Inc. is a member of the Coalition for Patent Fairness, comprised mainly of IT companies strongly seeking patent reform (including Amazon.com, Apple,… [read post]
24 Apr 2007, 4:18 pm
Bridgewood Servs., Inc., 290 F.3d 1364, 1373 (Fed. [read post]
23 Apr 2007, 9:23 pm
Singer -- AstraZeneca PLC announced on Monday that it plans to acquire MedImmune Inc. in a deal estimated to be worth about $15 billion. [read post]
23 Mar 2007, 11:35 am
Myers, serves as a patent reform template for the newly-formed Coalition for 21st Century Patent Reform, which includes 3M, Abbott Laboratories, Air Liquide, Air Products, AstraZeneca, Baxter Healthcare Corp., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel… [read post]
20 Mar 2007, 11:21 am
"Among the companies being sued under for such claims: AstraZeneca, Pfizer Inc., Johnson & Johnson, Amgen Inc., Eli Lilly & Co., GlaxoSmithKline PLC, Bayer Corp. and Hoffman-LaRoche Inc. [read post]
6 Feb 2007, 8:57 am
Singer In a February 5, 2007 press release Regeneron Pharmaceuticals, Inc. announced that it has entered into a non-exclusive license agreement with AstraZeneca involving Regeneron's VelocImmune ® antibody technology. [read post]
17 Jan 2007, 5:24 am
The companies that have been sued to date are Amgen, Inc.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
21 Nov 2006, 9:58 am
Medtronic AVE, Inc., 339 F.3d 1352, 1363 (Fed. [read post]
19 Oct 2006, 11:53 am
Inc.'s, Bristol-Myers Squibb Co.'s and last but not the least AstraZeneca PLC's. [read post]
29 Jun 2006, 5:04 pm
Goddard told Reuters Health that in its failed trial, AstraZeneca was using doses of Iressa one-third to two-thirds of the maximum tolerable dose. [read post]
